Prosecution Insights
Last updated: April 19, 2026

Yangtze River Pharmaceutical Group Co. Ltd.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
0
Final Rejections
3
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18579213 PHARMACEUTICALLY ACCEPTABLE SALT OF MOR RECEPTOR AGONIST, AND POLYMORPH THEREOF AND USE THEREOF HEASLEY, MEGHAN CHRISTINE 1626 Non-Final OA Jan 12, 2024
18262534 SUBSTITUTED PYRAZOLO[1,5-A]PYRIMIDINE-7-AMINE DERIVATIVES, COMPOSITIONS AND PHARMACEUTICAL USES THEREOF SEITZ, ANTHONY JOSEPH 1629 Non-Final OA Jul 21, 2023
17919402 SOLID PHARMACEUTICAL PREPARATION, PREPARATION METHOD THEREFOR AND USE THEREOF MARTIN, KEVIN STEPHEN 1624 Non-Final OA Oct 17, 2022

Managing Yangtze River Pharmaceutical Group Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month